Chromatographic analysis of site-specific antibody-drug conjugates produced by AJICAP first-generation technology using a recombinant FcγIIIa receptor-ligand affinity column
Yutaka Matsuda(Ajinomoto (United States)), Brian A. Mendelsohn(Seagen (United States)), Kunio Nakata(Ajinomoto (Japan)), Tatsuya Okuzumi(Suzuki (Japan)), Kazutoshi Takahashi(Suzuki (Japan)), Kei Yamada(Kurume University), Atis Chakrabarti
Cited by 29
Related Papers
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
|Nature Biotechnology|2003|1.2k
Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity
|Bioconjugate Chemistry|2005|511
Inhibitor hijacking of Akt activation
|Nature Chemical Biology|2009|296
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
|Breast Cancer Research|2009|156
A new alarm point of transcranial electrical stimulation motor evoked potentials for intraoperative spinal cord monitoring: a prospective multicenter study from the Spinal Cord Monitoring Working Group of the Japanese Society for Spine Surgery and Related Research
|Journal of Neurosurgery Spine|2013|144